Joseph P. Caruso
Directeur/Membre du Conseil chez LEXAGENE HOLDINGS INC.
Fortune : 1 897 $ au 31/01/2023
Profil
Joseph P.
Caruso is currently a Director at EndoCellutions, Inc. and an Independent Director at Lexagene Holdings, Inc. He was previously the Chairman, President & CEO at Palomar Medical Technologies LLC from 1992 to 2013 and Vice Chairman & President at Cynosure LLC in 2013.
He obtained his undergraduate degree from Merrimack College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LEXAGENE HOLDINGS INC.
0,01% | 19/12/2022 | 10 308 ( 0,01% ) | 1 897 $ | 31/01/2023 |
Postes actifs de Joseph P. Caruso
| Sociétés | Poste | Début |
|---|---|---|
| LEXAGENE HOLDINGS INC. | Directeur/Membre du Conseil | 18/06/2018 |
EndoCellutions, Inc.
 EndoCellutions, Inc. Medical SpecialtiesHealth Technology EndoCellutions, Inc. operates at the interface of devices and biologics, developing solutions to enable regenerative medicine. The company was founded by Jeff Chabot and Andy Levine and is headquartered in Marshfield, MA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Joseph P. Caruso
| Sociétés | Poste | Fin |
|---|---|---|
| CYNOSURE, INC. | President | 06/09/2013 |
| PALOMAR MEDICAL TECHNOLOGIES INC | President | 24/06/2013 |
Formation de Joseph P. Caruso
| Merrimack College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LEXAGENE HOLDINGS INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Palomar Medical Technologies LLC
 Palomar Medical Technologies LLC Electronic ComponentsElectronic Technology Palomar Medical Technologies LLC engages in the research, development, manufacturing and distribution of light based systems for cosmetic treatments. The company is involved in developing a differentiated product mix of light-based systems for various treatments through its research and development as well as with its partnerships throughout the world. It is continually developing and testing new indications to further the advancement in light-based treatments. The company operates through two segments: Professional Product and Consumer Product. The Professional Product segment includes all of its light-based products and services for the professional market. The Consumer Product segment includes PaloVia. It offers products based on technologies that include hair removal, body sculpting, including laser-assisted liposuction, removal of vascular lesions such as rosacea, spider veins, port wine stains and hemangiomas, wrinkle reduction, removal of leg veins, removal of benign pigmented lesions such as age and sun spots, freckles and melasma, tattoo removal, acne treatment, skin resurfacing, treatment of red pigmentation in hypertrophic and keloid scars, treatment of verrucae, skin tags, seborrheic keratosis, skin tightening through soft tissue coagulation, removal of scars, including acne scars, stretch marks and warts and soft tissue coagulation. Palomar Medical Technologies was founded in 1987 and is headquartered in Burlington, MA. | Electronic Technology |
Cynosure LLC
 Cynosure LLC Medical SpecialtiesHealth Technology Cynosure LLC engages in the development and manufacture of light-based aesthetic and medical treatment systems. Its treatment applications are used for hair removal, skin revitalization, scar reduction, gynaecological health, and body contouring and related activities. The company was founded on July 10, 1991 and is headquartered in Westford, MA. | Health Technology |
EndoCellutions, Inc.
EndoCellutions, Inc. Medical SpecialtiesHealth Technology EndoCellutions, Inc. operates at the interface of devices and biologics, developing solutions to enable regenerative medicine. The company was founded by Jeff Chabot and Andy Levine and is headquartered in Marshfield, MA. | Health Technology |
